View Online
June 6, 2019
News From Medscape
The following recommended articles on are freely available through the partnership between ABC and Medscape, no registration or login required.
HRS Consensus on Catheter Ablation of Ventricular Arrhythmias
The Heart Rhythm Society (HRS) has released a new consensus statement on catheter ablation of ventricular arrhythmias, with more focus on treatment of individual arrhythmias, preprocedural imaging and multielectrode mapping, substrate mapping and substrate-based ablation, among other topics.
Should ICDs in Primary Prevention Go the Way of Aspirin?
Times change. Therapies once proven beneficial may not remain so forever. Aspirin used to be effective for the primary prevention of cardiac events. Three large trials published last year showed that this is no longer the case. Aspirin's effects in the body have not changed. What's changed is the population and the underlying medical therapy.
More Than Half of Physicians Have Net Worth of at Least $1M
More than half of physicians have a net worth of more than $1 million, according to the Medscape Physician Wealth and Debt Report 2019. Forty-four percent have a net worth of $1 million to $5 million, and 7% have a net worth of more than $5 million.
Nonprofit Generic Drug Venture Civica Rx to Start With Two Antibiotics
Vancomycin and daptomycin are the first drugs that not-for-profit generic drug company Civica Rx will produce for its multiple health system members, the company announced Wednesday. Civica has reached an agreement with Copenhagen, Denmark-based Xellia Pharmaceuticals to manufacture the two intravenous antibiotics for its member health systems for 5 years, with the aim of avoiding drug shortages.
Items of Interest
ACC Names First Director of Diversity and Inclusion
The ACC has named Ranna Parekh, MD, MPH, as its first director of Diversity and Inclusion, effective July 29. By working with the ACC Task Force on Diversity and Inclusion and other societies and organizations, Parekh will lead and expand the College's diversity and inclusion initiatives to create a more diverse and inclusive environment within the field of cardiovascular disease and strive for a fully inclusive organization and profession.
Ethics Talk: What Are Clinicians' Obligations to Patients Who Express Bias or Discrimination?
This month on Ethics Talk, Dr Fatima Cody Stanford discusses a delicate tension between preserving relationships with patients who express bias and preserving one’s own dignity, and Dr Kimani Paul-Emile describes how organizations can support clinicians who experience bias, discrimination, or harassment.
History Of Lynchings In Southern States Affecting Health Outcomes Even Today
A study by researchers at the University of South Carolina found that counties in the United States with a history of lynchings have a higher mortality rate now than other counties.
AHA Scientific Statement on CVD and HIV
A new scientific statement from the American Heart Association (AHA) provides "pragmatic" recommendations on how to approach cardiovascular disease (CVD) prevention and management in the growing number of people living with HIV infection.
ACOG Releases Comprehensive Guidance on How to Treat the Leading Cause of U.S. Maternal Deaths: Heart Disease in Pregnancy
The American College of Obstetricians and Gynecologists (ACOG) released comprehensive guidance on pregnancy and heart disease. In the United States, cardiovascular disease (CVD) is now the leading cause of death in pregnancy and the postpartum period. It constitutes 26.5% of pregnancy-related deaths, with higher rates of mortality among women of color and women with lower incomes.
The Relationship Between Psoriasis and Cardiovascular Disease
Joel Gelfand, MD, of Penn Medicine in Philadelphia, dives into data on secukinumab and its effects on vascular inflammation in psoriasis patients, which were presented at the American Academy of Dermatology's recent annual meeting.
Biotronik Targets Women in Study of ICD Outcomes
Biotronik is targeting a minimum of 40% female enrollment for its newest project, a large-scale prospective study of sex differences in patients with non-ischemic cardiomyopathy (NICM) and an implanted cardiovascular device.
Featured Articles by Members
ABC Members: We welcome your published research submissions and articles for inclusion in future issues of Clinical Updates and Insights. Email Rachel Williams at and please attach file or include links to the original published work and/or abstract.
Characteristics, Outcomes, and Predictors of Significant Pericardial Complications in Patients who Underwent Transcatheter Aortic Valve Implantation
Co-authored by Gbolahan O Ogunbayo, MD (with Naoki Misumida, MD, Elliott Goodwin, MD, Robert Pecha, Ayman Elbadawi, MD, Claude S Elayi, MD, Ahmed Abdel-Latif, MD PhD, John Gurley, MD, Adrian W Messerli, MD, and Khaled Ziada, MD)
Large pericardial effusion and cardiac tamponade are known periprocedural complications of Transcatheter Aortic Valve Implantation (TAVR). Pericardial complications have also been associated with increased morbidity and mortality in patients who underwent permanent pacemaker insertion and percutaneous coronary intervention. This study describes characteristics, outcomes, and predictors of patients who develop significant pericardial complications related to TAVR.
Trends and Predictors of Palliative Care Referrals in Patients With Acute Heart Failure
Co-authored by Modele O. Ogunniyi, MD, MPH (Brijesh Patel, DO, Paul Secheresiu, DO, Mahek Shah, MD, Lekha Racharla, DO, Ahmad B. Alsalem, MD, Manyoo Agarwal, MD, Byomesh Tripathi, MD, Naveen Sablani, MD, Lohit Garg, MD, et al.)
The PCR is commonly utilized in terminal conditions such as metastatic cancers. There is no data on trends and predictors from large-scale registry of general population regarding PCR in patients with AHF. The object was to determine the rate and predictors of palliative care referral (PCR) in hospitalized patients with acute heart failure (AHF).
Fluoroquinolones and the Risk of Aortopathy: A Systematic Review and Meta-Analysis
Co-authored by Hakeem Ayinde (with Anas T. Noman, Abdul H. Qazi, Musab Alqasrawi, Imad M. Tleyjeh, Paul Lindower, Aref A. Bin Abdulhak)
To investigate the association between fluoroquinolones use and development of aortopathy, a systematic review and meta-analysis was conducted following PRISMA and MOOSE guidelines for reporting systematic reviews of observational studies. Multiple databases were searched and two authors independently screened studies for eligibility. Newcastle Ottawa scale was used to assessed the quality of included studies.
Meeting Highlights
ESC HEART FAILURE 2019: At the ESC Heart Failure Congress, Some COAPT Converts — and Some Pushback
One strong message that seemed to strike a chord with conference-goers was that secondary mitral regurgitation (MR) is first and foremost a heart failure disease and that heart failure specialists need to retain control of how and when their patients are treated.
EAS 2019: CHD Mortality Significantly Elevated in Patients With Severe FH
While individuals with familial hypercholesterolemia (FH) are at an increased risk of dying from coronary heart disease (CHD), a new study confirms that it’s those with the severest phenotype who are in particular jeopardy.
SCAI 2019: Cancer and CV Disease Care: What's Known? What Lies Ahead for Cardio-Oncology?
The emerging field of cardio-oncology, which seeks to treat cardiovascular conditions alongside a cancer diagnosis or in patients with a history of malignancy, requires a multidisciplinary team and a fresh approach to practice, according to experts who discussed both challenges and strategies here last week at SCAI 2019.
EUROPCR 2019: New Clarity on Patients at High Risk for Bleeding After PCI
An academic research consortium (ARC**) has waded into the question of how to precisely identify patients at high risk for bleeding when undergoing PCI, a definition that so far has lacked consistency.
**ABC Member Dr. Roxana Mehran is part of the consortium.
Upcoming Events